Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.
about
Proteomics, biomarkers, and HIV-1: A current perspectivePlasma proteomic profiling in HIV-1 infected methamphetamine abusersMethamphetamine and inflammatory cytokines increase neuronal Na+/K+-ATPase isoform 3: relevance for HIV associated neurocognitive disordersProteomic analysis of HIV-infected macrophagesSearching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date.Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging.Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma.Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics.Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.The landscape of viral proteomics and its potential to impact human health.PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disordersCommentary: Animal models of neuroAIDS.Short communication: quantitative proteomic plasma profiling reveals activation of host defense to oxidative stress in chronic SIV and methamphetamine comorbidityAnalysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.
P2860
Q26853681-9956DA83-6827-4835-B0E5-95D8C945722AQ28480898-52094CD8-0602-4678-AAF2-E01B78D76019Q28483960-346773B1-2530-49D1-86A4-5E77CB16373AQ33770687-A77472BC-3F13-478C-BC7E-9314AA71D3C4Q34342895-9BF7D483-CBE5-45F2-B024-41C81613C164Q35590466-DF5182A6-A130-4076-946F-2568096EBFACQ35773708-C0709443-E343-4187-8277-874809F6878DQ35825108-424A7A68-4B54-4759-A499-AA8F504EAA06Q37165264-7E2C7C95-99B4-49BE-BA25-BC6181C1F169Q37274112-921F7C31-F38A-408E-A5AB-EC1752A9BE90Q37504001-23508168-9AB9-4C91-9896-F124C329B7C2Q37549962-E71C3166-9BE6-4B74-B9BC-6798C67754A5Q38822395-3EA497AB-18D3-43A9-8AE8-DD75B5835B2BQ39620255-12F53F67-C34E-43A2-9118-3FEF8BDEF963Q40663824-5F71C126-D6D8-486B-9C4C-245CA77115AEQ41850246-2C5B5A24-9C3F-4652-87E4-F14AA982F152Q42143055-77315036-B9C8-47D5-8554-606D2275E73BQ47421750-30EA5588-129B-4E54-A19E-C91ECB4B7FBA
P2860
Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@ast
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@en
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@nl
type
label
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@ast
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@en
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@nl
prefLabel
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@ast
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@en
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@nl
P2860
P356
P1476
Quantitative plasma proteomic ...... or in SIV induced CNS disease.
@en
P2093
Gurudutt Pendyala
Sunia A Trauger
P2860
P304
P356
10.1021/PR900685U
P577
2010-01-01T00:00:00Z